Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelines.

Vernaz N, Rollason V, Adlere L, Combescure C, Poncet A, Bonnabry P, Desmeules J.

Pharmacol Res Perspect. 2016 Apr 21;4(3):e00234. doi: 10.1002/prp2.234. eCollection 2016 Jun.

2.

Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug Users.

Sogabe M, Okahisa T, Nakasono M, Fujino Y, Mitsui Y, Takaoka Y, Kimura T, Okamoto K, Muguruma N, Takayama T.

Medicine (Baltimore). 2015 Jul;94(26):e1047. doi: 10.1097/MD.0000000000001047.

3.

Effects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in rats.

Yu C, Qi D, Lian W, Li QZ, Li HJ, Fan HY.

PLoS One. 2014 Nov 6;9(11):e110124. doi: 10.1371/journal.pone.0110124. eCollection 2014.

4.

Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding.

Wang Q, Ljung R, Lagergren J, Lu Y.

BMC Pharmacol Toxicol. 2014 Apr 15;15:22. doi: 10.1186/2050-6511-15-22.

5.

Evaluation of the potentials of autologous blood injection for healing in diabetic foot ulcers.

Al Azrak M, Ismail T, Shaker O.

J Am Coll Clin Wound Spec. 2013 Jul 12;4(2):45-50. doi: 10.1016/j.jccw.2013.06.006. eCollection 2012 Jun.

6.

Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.

7.

Effects of preoperative aspirin on cardiocerebral and renal complications in non-emergent cardiac surgery patients: a sub-group and cohort study.

Cao L, Silvestry S, Zhao N, Diehl J, Sun J.

PLoS One. 2012;7(2):e30094. doi: 10.1371/journal.pone.0030094. Epub 2012 Feb 2.

8.

Peripheral arterial disease.

Cassar K.

BMJ Clin Evid. 2011 Jan 11;2011. pii: 0211. Review.

9.

Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient.

Kim SO, Han SY, Baek YH, Lee SW, Han JS, Kim BG, Cho JH, Nam KJ.

World J Gastroenterol. 2011 Jan 14;17(2):267-70. doi: 10.3748/wjg.v17.i2.267.

10.

Dual antiplatelet therapy in secondary prevention of ischemic stroke: a ghost from the past or a new frontier?

Balucani C, Barlinn K, Zivanovic Z, Parnetti L, Silvestrini M, Alexandrov AV.

Stroke Res Treat. 2010 Dec 29;2010:427418. doi: 10.4061/2010/427418.

11.

Gender dependence for a subset of the low-abundance signaling proteome in human platelets.

Eidelman O, Jozwik C, Huang W, Srivastava M, Rothwell SW, Jacobowitz DM, Ji X, Zhang X, Guggino W, Wright J, Kiefer J, Olsen C, Adimi N, Mueller GP, Pollard HB.

Hum Genomics Proteomics. 2010 Apr 13;2010:164906. doi: 10.4061/2010/164906.

12.

Management of atherothrombotic risk factors in high-risk Canadian outpatients.

Bell A, Hill MD, Herman RJ, Girard M, Cohen E; Canadian REduction of Atherothrombosis for Continued Health (REACH) Registry Steering Committee.

Can J Cardiol. 2009 Jun;25(6):345-51.

13.

Peripheral arterial disease.

Cassar K.

BMJ Clin Evid. 2007 Jul 1;2007. pii: 0211. Review.

14.

Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients.

Schwartz KA, Schwartz DE, Barber K, Reeves M, De Franco AC.

J Transl Med. 2008 Aug 29;6:46. doi: 10.1186/1479-5876-6-46.

15.

Long term medical treatment of stable coronary disease.

Shavelle DM.

Heart. 2007 Nov;93(11):1473-7. Review. No abstract available.

16.

A cross sectional survey of secondary prevention measures in patients with peripheral arterial disease in primary care.

Dunkley A, Stone M, Sayers R, Farooqi A, Khunti K.

Postgrad Med J. 2007 Sep;83(983):602-5.

17.

Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study.

Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Andersen M, Lassen AT.

BMJ. 2006 Oct 7;333(7571):726. Epub 2006 Sep 19.

18.

Prevalence of antiplatelet therapy in patients with diabetes.

Miller SR, Littenberg B, MacLean CD.

Cardiovasc Diabetol. 2005 Dec 1;4:18.

Items per page

Supplemental Content

Write to the Help Desk